The January 2007 issue of Harvard Men's Health Watch highlights a number of recent findings on the crucial role that chromium plays in human health. Published by USA-based Harvard Medical School, the journal reports new data showing that, in rats, chromium deficiency leads to high cholesterol levels, though it noted that in humans the results have been contradictory.
According to the review article, with such scattered findings, it is too early to recommend chromium supplements for cholesterol. But there may be an exception to that rule when it comes to low high-density lipoprotein cholesterol. While the best ways to boost HDL are lifestyle changes such as exercise and diet, if those do not help, chromium may be worth a try, as some clinical trials have reported a benefit, according to the Harvard report, which also notes the results of a new study showing the lower levels of chromium the higher the risk.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze